JavaScript NENÍ povolen !

Prosím povolte JavaScript.

Článek

PubMed

Záznam pochází z PubMed

Letter to Editor: F.S. Kaplan, et al., Early clinical observations on the use of imatinibmesylate in FOP: A report of seven cases, Bone (2017)

Rohleder, O
Autor Rohleder, O Pediatric Oncology Department, University Hospital Brno and School of Medicine, Masaryk University, Cernopolni 9, Brno 613 00, Czech Republic; Division of Medical Genetics, Department of Biology, University Hospital Brno and School of Medicine, Masaryk University, Cernopolni 9, Brno 613 00, Czech Republic. Electronic address: ondrej.rohleder@fnbrno.cz
Mudry, P
Autor Mudry, P Pediatric Oncology Department, University Hospital Brno and School of Medicine, Masaryk University, Cernopolni 9, Brno 613 00, Czech Republic. Electronic address: pmudry@fnbrno.cz
Neradil, J
Autor Neradil, J Pediatric Oncology Department, University Hospital Brno and School of Medicine, Masaryk University, Cernopolni 9, Brno 613 00, Czech Republic; Laboratory of Tumor Biology, Department of Experimental Biology, School of Science, Masaryk University, Kotlarska 2, Brno 611 37, Czech Republic. Electronic address: jneradil@sci.muni.cz
Noskova, H
Autor Noskova, H Central European Institute of Technology, Masaryk University, Kamenice 753/5, Brno 625 00, Czech Republic. Electronic address: hana.noskova@ceitec.muni.cz
Slaby, O
Autor Slaby, O Central European Institute of Technology, Masaryk University, Kamenice 753/5, Brno 625 00, Czech Republic. Electronic address: ondrej.slaby@ceitec.muni.cz
Sterba, J
Autor Sterba, J Pediatric Oncology Department, University Hospital Brno and School of Medicine, Masaryk University, Cernopolni 9, Brno 613 00, Czech Republic. Electronic address: jsterb@fnbrno.cz

Bone. 2018 Nov ; 116 () : 171. [epub] 20180807

ISSN 1873-2763
Zdroj

Jazyk angličtina Země Spojené státy americké Médium print-electronic

Typ dokumentu kazuistiky, dopisy

Perzistentní odkaz https://www.medvik.cz/link/pmid30096467

PubMed 30096467
DOI 10.1016/j.bone.2018.08.003
PII: S8756-3282(18)30304-1
Knihovny.cz E-zdroje

MeSH
imatinib mesylát farmakologie terapeutické užití MeSH
kojenec MeSH
kosti a kostní tkáň účinky léků patologie MeSH
lidé MeSH
mutace genetika MeSH
myositis ossificans farmakoterapie genetika MeSH
Check Tag
kojenec MeSH
lidé MeSH
ženské pohlaví MeSH
Publikační typ
dopisy MeSH
kazuistiky MeSH
Názvy látek
imatinib mesylát MeSH

Central European Institute of Technology Masaryk University Kamenice 753 5 Brno 625 00 Czech Republic

Pediatric Oncology Department University Hospital Brno and School of Medicine Masaryk University Cernopolni 9 Brno 613 00 Czech Republic

Pediatric Oncology Department University Hospital Brno and School of Medicine Masaryk University Cernopolni 9 Brno 613 00 Czech Republic; Division of Medical Genetics Department of Biology University Hospital Brno and School of Medicine Masaryk University Cernopolni 9 Brno 613 00 Czech Republic

Pediatric Oncology Department University Hospital Brno and School of Medicine Masaryk University Cernopolni 9 Brno 613 00 Czech Republic; Laboratory of Tumor Biology Department of Experimental Biology School of Science Masaryk University Kotlarska 2 Brno 611 37 Czech Republic

Přidružená publikace

Bone. 2018 Apr;109:276-280. doi: 10.1016/j.bone.2017.07.019. PubMed

Citace poskytuje Crossref.org

Nejnovějších 20 citací...

Zobrazit více v
Medvik | PubMed

Phospho-Protein Arrays as Effective Tools for Screening Possible Targets for Kinase Inhibitors and Their Use in Precision Pediatric Oncology

Frontiers in oncology. 2019 ; 9 () : 930. [epub] 20190920

Front Oncol
ISSN 2234-943X
Zdroj

Najít záznam

v BMČ

Letter to Editor: F.S. Kaplan, et al., Early clinical observations on the use of imatinibmesylate in FOP: A report of seven cases, Bone (2017)

Najít záznam

Citační ukazatele

Možnosti archivace